[144] MetLife, Inc. SEC Filing

Rhea-AI Filing Summary

MetLife, Inc. (MET) has filed a Form 144 with the U.S. Securities and Exchange Commission disclosing a planned sale of 27 shares of its common stock. The shares, carrying an aggregate market value of $2,120.85, are slated for sale on or about 20 June 2025 through Barclays Capital, 745 Seventh Ave, New York, NY 10019. The notice cites 671,297,826 shares outstanding, making the proposed transaction an immaterial fraction of total equity.

The filer also reported prior dispositions over the past three months totaling 686 shares for gross proceeds of roughly $55,392, executed on 21 March 2025 and 13 June 2025 by various MetLife-related accounts. The signing party affirms that no undisclosed material adverse information exists and that Rule 10b5-1 representations are satisfied.

Insights

Securities Analyst

Tiny 27-share Form 144 sale; negligible impact on MetLife shares.

The filing signals an insider or affiliate intent to sell a mere 27 shares, valued at about $2.1 k. Relative to 671 million shares outstanding, the stake is statistically insignificant and should not influence liquidity, ownership concentration, or valuation metrics. The additional 686 shares sold in the prior quarter likewise represent de minimis volume. No strategic, operational, or financial disclosures accompany the notice, and the filer certifies the absence of undisclosed adverse information. Overall, the event is routine and unlikely to alter investor sentiment.

Corporate Governance Expert

Routine compliance filing; reflects standard Rule 144 insider sale controls.

Form 144 demonstrates the issuer’s governance processes are functioning as insiders follow SEC disclosure rules. The minuscule size—27 shares—suggests no substantive shift in insider confidence or control. The certification language confirms adherence to Rule 10b5-1 safeguards, reducing legal or reputational risk. From a governance standpoint, the filing is a non-event, offering transparency without conveying new risk or opportunity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Barclays Capital 745 Seventh Ave New York NY 10019	27	2120.85	671297826	06/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/11/2021	Purchase	Citigroup Global Markets			27	10/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	335	27590.6
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	77	6341.72
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	47	3870.92
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	03/21/2025	6	494.16
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/13/2025	221	17094.35

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many MetLife (MET) shares are proposed for sale in the Form 144?

The filing covers 27 shares of MetLife common stock.

What is the aggregate market value of the proposed MET share sale?

The 27 shares have an aggregate market value of $2,120.85.

When is the approximate sale date for the shares disclosed in MetLife's Form 144?

The shares are expected to be sold on or about June 20, 2025.

Which broker is handling the proposed MetLife share sale?

The broker is Barclays Capital, 745 Seventh Ave, New York, NY 10019.

How many MetLife shares are currently outstanding according to the filing?

The notice lists 671,297,826 shares outstanding.

What volume of MetLife shares has been sold by the filer in the past three months?

Sales over the past three months total 686 shares for about $55,392 in gross proceeds.